You have no items in your cart.
Shape Therapeutics Raises $112M to Develop RNA-based Gene Therapies
Shape Therapeutics has raised $112 million in financing to support work into developing its portfolio ...
More from COVID-19 News and Columns
-
-
Please Be Mindful When Speaking to Someone With a Chronic Illness
When speaking to a person with a chronic illness, you might do and say things ... -
Learning My Limitations and Planning Ahead Makes Summer Enjoyable
Something about sunshine boosts my mood. Do you find that to be true, too? For ... -
The Friends and Fate I Chose Thanks to ‘Dragon Age: Inquisition’
I never planned on writing about video games for my column. But after three columns ... -
Specific Fibroblast Cells Prevent Fibrosis in PF Mouse Model Study
A subset of fibroblasts that produce a protein called meflin in lung tissues taken from ... -
Ultomiris Helps Ease gMG Symptoms in Ongoing Phase 3 Trial
Ultomiris (ravulizumab-cwvz) rapidly and sustainably eased symptom severity in adults with generalized myasthenia gravis (gMG), ... -
Work in Progress on Challenges of Minority Representation in CF Trials
Proper representation in clinical trials has long been a challenge for minorities with rare diseases ... -
Masitinib, Given Early in ALS Course, Extends Life, Trial Data Show
Treatment with the investigational oral therapy masitinib can extend lifespan when given early in the ... -
DMD Trial Testing Oral ASP0367 Recruiting Boys 8–16 in US
A Phase 1b clinical trial evaluating Astellas Pharma’s ASP0367 is recruiting boys with Duchenne muscular dystrophy ... -
Lungs ‘Primed’ for Severe COVID-19 in People With IPF, Like Disorders
Changes in gene activity and immune cell populations in the lungs of people with chronic ... -
What Happens When the Carer Needs Care?
I’ve been sick for most of this week with digestive issues. This is a chronic ... -
How to Avoid the Caregiver-Alzheimer’s Battleground
Familial caregivers are supposed to advocate for loved ones, but a person with dementia may ... -
Early Phase 1 Data Support PHA121 as Oral HAE Prophylactic
Multiple doses of PHA121 (PHA-022121), an investigational oral therapy for hereditary angioedema (HAE), were well-tolerated ... -
‘Wearable Cyborg’ Helps Improve Walking Ability, Muscle Strength
A wearable cybernetic leg significantly improved the gait and ability to perform walking exercises of ... -
How to Enjoy Travel With Duchenne Muscular Dystrophy
Last week, I traveled to the headquarters of my employer, BioNews, the publisher of Muscular ...